|Generate QR code
Open Access
Subscription Access
Involvement of the intestinal microbiome in the tumor process of the gastrointestinal tract
https://doi.org/10.29235/1818-9857-2022-7-74-79
Abstract
The article assesses the degree of participation of the microbiome in the development of the pre-tumor process of the gastrointestinal tract. The necessity of studying the pathology of the gastrointestinal tract at the genetic level in relation to the persistence of microorganisms that affect the expression of human genes is shown: their proteins and metabolites interact with the genome, modifying it. The role of opportunistic microflora in the regulation of the immune response in patients with cancer and changes in microbiocenosis in lesions of the large intestine, liver and pancreas, as well as its significance in carcinogenesis are presented. The need for further studies of the mechanisms of development of the tumor process of the gastrointestinal tract and determination of the relationship between the microbiome, the human immune system and carcinogenesis is emphasized.
About the Authors
O. Kuznetsov
Институт биохимии биологически активных соединений НАН Беларуси; Гродненский государственный медицинский университет
Belarus
Belarus
V. Tsyrkunov
Гродненский государственный медицинский университет
Belarus
Belarus
References
1. А.М. Курильщиков. Методы и объекты метагеномных исследований / А.М. Курильщиков, Н.В. Тикунова, М.Р. Кабилов // Вестник НГУ, Серия: Биология, клиническая медицина. 2012. Том 12 (выпуск 1). C. 191–201.
2. P.J. Turnbaugh. The human microbiome project / P.J. Turnbaugh, R.E. Ley, M. Hamady [et al.] // Nature. 2007. Vol. 449 (7164). P. 804–810. doi: 10.1038 / nature06244.
3. S.P. Yenamandra. Nuclear receptors and their role in Epstein-Barr virus induced B cell transformation. Review / S.P. Yenamandra, G. Klein, E. Kashuba // Experimental Oncology. 2009. Vol. 31 (2). P. 67–73.
4. Т.А. Clayton. Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism / T.A. Clayton, D. Baker, J.C. Lindon [et al.] // Proc. Natl. Acad. Sci. USA. 2009. Vol. 106 (34). P. 28–33. doi:10.1073/pnas.0904489106.
5. К. Mima. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis / K. Mima, R. Nishihara, Z.R. Qian [et al.] // Gut. 2016. Vol. 65 (12). P. 1973–1980. doi:10.1136 / gutjnl-2015–310101.
6. J. Repass. Biology RPC. Registered report: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma / J. Repass, N. Maherali, К. Owen // Elife. 2016. 5. P. 10–12. doi:10.7554/eLife.10012.
7. О.Е. Кузнецов. Вирусассоциированный рак печени / О.Е. Кузнецов, В.М. Цыркунов // Гепатология и гастроэнтерология. 2021. Том 5(1). С. 17–24. doi.org/10.25298/2616–5546–2021–5–1–17–24.
8. A.G. Neto. Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma / A.G. Neto, A. Whitaker, Z. Pei // Semin Oncol. 2016. Vol. 43. P. 86–96. doi:10.1053/j.seminoncol.
9. F. Aviles-Jimenez. Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer / F. Aviles-Jimenez, F. Vazquez-Jimenez, R. Medrano-Guzman [et al.] // Sci Rep. 2014. Vol. 4:4202. doi:10.1038/srep04202.
10. E.D. Kuugbee. Structural change in microbiota by a probiotic cocktail enhances the gut barrier and reduces cancer via TLR2 signaling in a rat model of colon cancer / E.D. Kuugbee, X. Shang, Y. Gamallat [et al.] // Dig Dis Sci. 2016. Vol. 61 (10). P. 2908–2920. doi:10.1007/s10620–016–4238–7.
11. B. Ou. Survival of colorectal cancer in patients with or without inflammatory bowel disease: a metaanalysis / B. Ou, J. Zhao, S. Guan, A. Lu // Dig Dis Sci. 2016. Vol. 61 (3). P. 881–889. doi:10.1007/s10620–015–3940–1.
12. O.I. Coleman. Role of the microbiota in colorectal cancer: updates on microbial associations and therapeutic implications / O. I. Coleman, T. Nunes // Biores Open Access. 2016. Vol. 5 (1). P. 279–288. doi:10.1089/ biores.2016.0028.
13. W. Borena. Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults / W. Borena, S. Strohmaier, A. Lukanova [et al.] // Int. J. Cancer. 2012. Vol.131(1). P. 193–200. doi:10.1002/ijc.26338.
14. P. Ambalam. Probiotics, prebiotics and colorectal cancer prevention / P. Ambalam, M. Raman, R.K. Purama, M. Doble // Best Pract Res Clin Gastroenterol. 2016. Vol. 30 (1). P. 119–131. doi:10.1016/j.bpg.2016.02.009.
Review
For citations:
Kuznetsov O., Tsyrkunov V. Involvement of the intestinal microbiome in the tumor process of the gastrointestinal tract. Science and Innovations. 2022;1(7):74-79. (In Russ.) https://doi.org/10.29235/1818-9857-2022-7-74-79
Views: 784
Email this article 